Latest Gynecomastia Stories
The Firm is representing numerous clients in Risperdal lawsuits that have been filed in the Pennsylvania mass tort proceeding, all of whom allegedly developed gynecomastia due to treatment with
The Risperdal trial currently underway in the Pennsylvania mass tort, where Bernstein Liebhard LLP is actively filing claims, is the first to involve gynecomastia, and could provide insight into
The Firm is representing numerous gynecomastia plaintiffs who have Risperdal lawsuits pending in the same mass tort litigation.
The Firm is representing numerous plaintiffs who have also filed Risperdal lawsuits alleging the atypical antipsychotic medication caused male breast growth. New
Trial in Philadelphia involves allegations that Janssen Pharmaceuticals and parent company, Johnson & Johnson, failed to warn about the risks of male breast growth, a condition known as gynecomastia,
The Firm is representing numerous gynecomastia plaintiffs in Risperdal lawsuits that are now pending in the same Pennsylvania mass tort litigation. New York,
The Firm is representing numerous Risperdal lawsuit plaintiffs who are also alleged to have developed gynecomastia due to their use of the atypical antipsychotic medication. New
A former U.S.
Defense motion granted in a case that is part of a mass tort litigation brought over Janssen Pharmaceutical’s antipsychotic medication, Risperdal. Port Washington,
The Firm is currently representing numerous Risperdal lawsuit plaintiffs in the Pennsylvania litigation, all of whom allegedly developed gynecomastia (male breast growth) due to their use of the
- To fire mitraille at.